A novel effect of geraniin on OPG/RANKL signaling in osteoblasts

A novel effect of geraniin on OPG/RANKL signaling in osteoblasts

In this study, the effects of geraniin on osteoprotegerin/receptor activator of nuclear factor-κB ligand(OPG/RANKL) in regulating the proliferation of osteoblasts and suppression of osteoclast-like cells (OLC) in OLC-osteoblast co-cultured system in vitro were investigated. Osteoblasts were cultured...

Full description

Bibliographic Details
Main Authors:	Xiaochao Zhang, Renhua Yang, Jiang Long, Bo He, Yue Zhang, Ting Fu, Zhiqiang Shen, Peng Chen
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2018-11-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Geraniin/effect Osteoblasts Osteoprotegerin Receptor activator of nuclear factor -κ B ligand.
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000300618&lng=en&tlng=en

Similar Items

Probiotic <i>Propionibacterium freudenreichii</i> MJ2 Enhances Osteoblast Differentiation and Mineralization by Increasing the OPG/RANKL Ratio
by: Jiah Yeom, et al.
Published: (2021-03-01)

OPG/RANKL/RANK cytokine system in renal osteodystrophy
by: Ivica Avberšek-Lužnik, et al.
Published: (2007-11-01)

Geraniin ameliorates streptozotocin-induced diabetic retinopathy in rats via modulating retinal inflammation and oxidative stress
by: Zhimin Yu, et al.
Published: (2023-01-01)

Rank-Rankl-Opg Axis in Multiple Sclerosis: The Contribution of Placenta
by: Sofia Passaponti, et al.
Published: (2022-04-01)

Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats
by: Mehmet SAĞLAM, et al.
Published: (2015-02-01)

S-Equol enhances osteoblastic bone formation and prevents bone loss through OPG/RANKL via the PI3K/Akt pathway in streptozotocin-induced diabetic rats
by: Zhe Xu, et al.
Published: (2022-10-01)

The Influence of Prenatal Fumonisin Exposure on Bone Properties, as well as OPG and RANKL Expression and Immunolocalization, in Newborn Offspring Is Sex and Dose Dependent
by: Ewa Tomaszewska, et al.
Published: (2021-12-01)

PEG-b-PLGA Nanoparticles Loaded with Geraniin from <i>Phyllanthus Watsonii</i> Extract as a Phytochemical Delivery Model
by: Kogilavanee Devasvaran, et al.
Published: (2020-07-01)

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids
by: Salvador Atilano-Miguel, et al.
Published: (2022-01-01)

An insight in to Paget′s disease of bone
by: Robin Sabharwal, et al.
Published: (2014-01-01)

Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor
by: Young Soo Kim, et al.
Published: (2021-08-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
by: Riham Eid, et al.
Published: (2023-06-01)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
by: Sheng Zhu, et al.
Published: (2020-12-01)

Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis
by: Michalis Spartalis, et al.
Published: (2023-02-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
by: Chan Kai-Ming, et al.
Published: (2011-07-01)

Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway
by: Xiao-Feng He, et al.
Published: (2017-11-01)

Pangasius djambal gelatin increases osteoprotegerin, decreases RANK and RANKL after tooth extraction in vivo
by: Fredy Mardiyantoro, et al.
Published: (2023-12-01)

Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
by: Anita J.W.M. Brouns, et al.
Published: (2023-05-01)

The Geraniin-Rich Extract from Reunion Island Endemic Medicinal Plant <i>Phyllanthus phillyreifolius</i> Inhibits Zika and Dengue Virus Infection at Non-Toxic Effect Doses in Zebrafish
by: Juliano G. Haddad, et al.
Published: (2020-05-01)

Diagnostic potential of salivary interleukin‐17, RANKL, and OPG to differentiate between periodontal health and disease and discriminate stable and unstable periodontitis: A case‐control study
by: Marwa A. Abdullameer, et al.
Published: (2023-02-01)

The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells
by: Masanobu Tsubaki, et al.
Published: (2020-10-01)

LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro
by: Ineke D.C. Jansen, et al.
Published: (2020-08-01)

Bone remodeling serum markers in children with systemic lupus erythematosus
by: Sheng Hao, et al.
Published: (2022-07-01)

Effect of anatomical location (mandible vs maxilla) of dental implants on the BMP-2, BMP-7, sRANKL and OPG levels in periimplant crevicular fluid during osseointegration. A pilot study
by: Mehmet Sağlam, et al.
Published: (2019-12-01)

Recovery of Bioactive Ellagitannins by Ultrasound/Microwave-Assisted Extraction from Mexican Rambutan Peel (<i>Nephelium lappaceum</i> L.)
by: Luis Estrada-Gil, et al.
Published: (2022-02-01)

Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis
by: Xu Han, et al.
Published: (2022-11-01)

Osteoclastic activity was associated with the development of steroid-induced osteonecrosis of femoral head
by: Min-Cong He, et al.
Published: (2020-01-01)

1, 25-dihydroxy vitamin D3 alleviates collagen-induced arthritis via regulating Th17/Treg ratio and RANKL/OPG axis
by: QI Kun, et al.
Published: (2023-08-01)

The ATF3–OPG Axis Contributes to Bone Formation by Regulating the Differentiation of Osteoclasts, Osteoblasts, and Adipocytes
by: Jung Ha Kim, et al.
Published: (2022-03-01)

THE ROLE OF OSTEOPROTEGERIN SYSTEM /RANKL/RANK IN PATHOGENESIS OF AORTIC STENOSIS
by: O. B. Irtyuga, et al.
Published: (2018-03-01)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
by: Guanghao Chi, et al.
Published: (2023-11-01)

Structural and functional state of bone tissue in young people with a combined course of osteoarthritis and obesity
by: Anastasiia Litvynova
Published: (2022-06-01)

Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling
by: Luodan Zhang, et al.
Published: (2022-11-01)

Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study
by: Dured Dardari, et al.
Published: (2022-04-01)

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?
by: Aleksandra Mielczarek-Palacz, et al.
Published: (2020-03-01)

Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study
by: Osama E. Amer, et al.
Published: (2022-07-01)

Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
by: Lane Denis, et al.
Published: (2012-11-01)

Geniposide suppressed OX-LDL-induced osteoblast apoptosis by regulating the NRF2/NF-κB signaling pathway
by: Yaosheng Xiao, et al.
Published: (2023-08-01)

The Roadmap of RANKL/RANK Pathway in Cancer
by: Sandra Casimiro, et al.
Published: (2021-08-01)

EFFECT OF INFLIXIMAB ON PARAMETERS OF REMODELING OF ARTERIAL BLOODSTREAM, RANKL AND OSTEOPROTEGERIN LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Larisa Aleksandrovna Knyazeva, et al.
Published: (2014-02-01)